FibroGen (NASDAQ:FGEN) Now Covered by Analysts at StockNews.com
Research analysts at StockNews.com initiated coverage on shares of FibroGen (NASDAQ:FGEN – Get Free Report) in a note issued to investors on Saturday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Several other equities research analysts have also recently weighed in on the company. HC Wainwright reissued a “buy” rating and issued […]
Research analysts at StockNews.com initiated coverage on shares of FibroGen (NASDAQ:FGEN – Get Free Report) in a note issued to investors on Saturday. The brokerage set a “hold” rating on the biopharmaceutical company’s stock. Several other equities research analysts have also recently weighed in on the company. HC Wainwright reissued a “buy” rating and issued […]
